Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Neovascularization, Pathologic | 3 | 2021 | 305 | 1.34 | Why? |
Pilonidal Sinus | 2 | 2018 | 11 | 0.91 | Why? |
Surgical Wound | 2 | 2018 | 20 | 0.90 | Why? |
Platelet-Rich Plasma | 2 | 2018 | 91 | 0.82 | Why? |
Obstetric Labor, Premature | 1 | 2020 | 114 | 0.79 | Why? |
Pregnancy Complications, Hematologic | 1 | 2021 | 114 | 0.79 | Why? |
Hemarthrosis | 1 | 2017 | 4 | 0.73 | Why? |
Angiogenesis Inducing Agents | 1 | 2017 | 11 | 0.73 | Why? |
Wound Healing | 2 | 2018 | 424 | 0.64 | Why? |
Cannabinoids | 1 | 2016 | 134 | 0.56 | Why? |
Inflammation | 5 | 2021 | 13255 | 0.53 | Why? |
Cesarean Section | 2 | 2021 | 2089 | 0.51 | Why? |
Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 645 | 0.49 | Why? |
Endothelial Cells | 1 | 2021 | 2048 | 0.42 | Why? |
Methylprednisolone | 1 | 2021 | 2107 | 0.42 | Why? |
Shock, Septic | 1 | 2020 | 1313 | 0.40 | Why? |
Pregnancy Complications, Infectious | 2 | 2021 | 11559 | 0.28 | Why? |
Graft vs Host Disease | 2 | 2018 | 501 | 0.25 | Why? |
Psoriasis | 1 | 2016 | 1739 | 0.24 | Why? |
Pulse Therapy, Drug | 1 | 2021 | 137 | 0.23 | Why? |
HELLP Syndrome | 1 | 2021 | 52 | 0.22 | Why? |
Coinfection | 1 | 2021 | 6820 | 0.22 | Why? |
Fluorocarbons | 1 | 2021 | 102 | 0.21 | Why? |
Plasminogen Activator Inhibitor 1 | 1 | 2021 | 162 | 0.21 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.20 | Why? |
Lipoproteins | 1 | 2021 | 240 | 0.20 | Why? |
Drug Resistance | 1 | 2021 | 395 | 0.19 | Why? |
Photopheresis | 1 | 2018 | 33 | 0.18 | Why? |
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 291 | 0.18 | Why? |
Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.18 | Why? |
Hyperbilirubinemia | 1 | 2018 | 81 | 0.18 | Why? |
Iran | 2 | 2021 | 5467 | 0.18 | Why? |
Receptors, Cannabinoid | 1 | 2016 | 9 | 0.17 | Why? |
Corneal Topography | 1 | 2017 | 45 | 0.17 | Why? |
Peripheral Blood Stem Cell Transplantation | 1 | 2017 | 86 | 0.17 | Why? |
Keratoconus | 1 | 2017 | 42 | 0.16 | Why? |
Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 121 | 0.16 | Why? |
Joint Diseases | 1 | 2017 | 122 | 0.16 | Why? |
Influenza, Human | 1 | 2021 | 10779 | 0.16 | Why? |
Health Planning Guidelines | 1 | 2017 | 133 | 0.16 | Why? |
Keratinocytes | 1 | 2016 | 119 | 0.15 | Why? |
Diagnostic Techniques, Ophthalmological | 1 | 2017 | 136 | 0.15 | Why? |
Intercellular Adhesion Molecule-1 | 1 | 2016 | 189 | 0.15 | Why? |
Interleukin-1beta | 1 | 2021 | 992 | 0.15 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.15 | Why? |
Transplantation Conditioning | 1 | 2017 | 323 | 0.15 | Why? |
Blood Component Removal | 1 | 2017 | 175 | 0.15 | Why? |
Platelet Count | 1 | 2021 | 1381 | 0.14 | Why? |
von Willebrand Factor | 1 | 2021 | 668 | 0.14 | Why? |
Photography | 1 | 2017 | 255 | 0.14 | Why? |
Papillomaviridae | 1 | 2019 | 404 | 0.14 | Why? |
Pregnancy | 3 | 2021 | 23879 | 0.13 | Why? |
Nitric Oxide | 1 | 2021 | 769 | 0.13 | Why? |
Myopia | 1 | 2017 | 189 | 0.13 | Why? |
Cell Movement | 1 | 2016 | 695 | 0.12 | Why? |
Angiogenesis Inhibitors | 1 | 2016 | 395 | 0.12 | Why? |
Vascular Endothelial Growth Factor A | 1 | 2016 | 604 | 0.12 | Why? |
Hemophilia A | 1 | 2017 | 362 | 0.12 | Why? |
Interleukin-17 | 1 | 2016 | 602 | 0.11 | Why? |
Photochemotherapy | 1 | 2017 | 297 | 0.11 | Why? |
Body Weight | 1 | 2017 | 1074 | 0.11 | Why? |
Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.11 | Why? |
Interleukin-8 | 1 | 2016 | 964 | 0.11 | Why? |
Hematologic Diseases | 1 | 2017 | 614 | 0.11 | Why? |
Papillomavirus Infections | 1 | 2019 | 861 | 0.10 | Why? |
Anti-Inflammatory Agents | 2 | 2020 | 6153 | 0.10 | Why? |
Cell Proliferation | 1 | 2016 | 1973 | 0.09 | Why? |
Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
Seasons | 1 | 2021 | 4071 | 0.09 | Why? |
Blood Coagulation | 1 | 2021 | 2768 | 0.09 | Why? |
Pregnancy Outcome | 1 | 2020 | 3803 | 0.08 | Why? |
Pregnant Women | 1 | 2020 | 2535 | 0.08 | Why? |
Humans | 17 | 2021 | 930598 | 0.08 | Why? |
Treatment Outcome | 3 | 2021 | 51732 | 0.07 | Why? |
Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
Neutrophils | 1 | 2020 | 5476 | 0.07 | Why? |
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
Cytokines | 2 | 2021 | 15010 | 0.06 | Why? |
Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
Young Adult | 3 | 2021 | 93724 | 0.05 | Why? |
Breast Neoplasms | 1 | 2019 | 3633 | 0.05 | Why? |
Infant, Newborn | 1 | 2021 | 23105 | 0.05 | Why? |
Cell Transformation, Viral | 1 | 2019 | 21 | 0.05 | Why? |
Hospitalization | 2 | 2021 | 54280 | 0.05 | Why? |
Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
Protective Agents | 1 | 2021 | 250 | 0.05 | Why? |
Retrospective Studies | 2 | 2020 | 105322 | 0.05 | Why? |
Female | 6 | 2021 | 380317 | 0.04 | Why? |
Models, Theoretical | 1 | 2016 | 6659 | 0.04 | Why? |
Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
Gels | 1 | 2017 | 111 | 0.04 | Why? |
Adult | 5 | 2020 | 244371 | 0.04 | Why? |
Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
Time Factors | 1 | 2018 | 31397 | 0.03 | Why? |
NF-kappa B | 1 | 2021 | 1301 | 0.03 | Why? |
Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
Child | 2 | 2020 | 70012 | 0.03 | Why? |
Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
Gene Expression Regulation, Viral | 1 | 2019 | 925 | 0.03 | Why? |
Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
Animals | 2 | 2021 | 78931 | 0.03 | Why? |
Visual Acuity | 1 | 2017 | 790 | 0.03 | Why? |
Biomarkers, Tumor | 1 | 2019 | 1314 | 0.02 | Why? |
Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
Male | 5 | 2021 | 367725 | 0.02 | Why? |
DNA, Viral | 1 | 2019 | 2521 | 0.02 | Why? |
Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
Tissue Donors | 1 | 2017 | 1679 | 0.02 | Why? |
Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
Genotype | 1 | 2019 | 4697 | 0.02 | Why? |
Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
Middle Aged | 2 | 2020 | 270681 | 0.02 | Why? |
Aged | 1 | 2020 | 215776 | 0.02 | Why? |
Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
Infant | 1 | 2017 | 30274 | 0.01 | Why? |
Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
Norooznezhad's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_